欧州の歯科用軟組織再生市場（2020年～2026年）： MedCore

欧州の歯科用軟組織再生市場は、2019年に730万ユーロと評価されました。市場全体に対するCOVID-19の影響を受け売上は増加し、2026年までに990万ユーロに達すると予測されています。販売台数の大部分を占めるのはGeistlich社とBotiss社のキセノングラフト製品であり、残りの大半はBioHorizons社が販売するAlloDerm®となっています。軟部組織再生のためのヒト組織の使用をめぐる規制が欧州全域におけるこれら製品の販売を妨げているものの、特に歯科領域では規制のハードルはやや低くなっていると考えられます。

当レポートは、欧州の歯科用軟組織再生市場について調査しており、COVID-19の影響、市場予測、成長および抑制要因、シェアなどの情報を提供しています。

目次

目次

図のリスト

チャートのリスト

調査手法

手術件数

欧州の歯科用軟組織再生市場に対するCOVID-19の影響

• イントロダクション
• マルチシナリオ分析

欧州の歯科用軟組織再生市場

• イントロダクション
• 市場分析と予測
• 成長および抑制要因
  • 市場成長要因
  • 市場抑制要因
• 競争市場シェア分析

略語

LIST OF CHARTS

• Chart 2 1: Dental Soft Tissue Regeneration Procedure Numbers, Europe, 2016 - 2026 16
• Chart 3 1: Multi-Scenario Dental Soft Tissue Regeneration Market, Europe, 2016 - 2026 (€M) 20
• Chart 4 1: Dental Soft Tissue Regeneration Market, Europe, 2019 - 2026 (€M) 26
• Chart 4 2: Leading Competitors, Dental Soft Tissue Regeneration Market, Europe, 2019 39

LIST OF FIGURES

• Figure 2 1: Dental Soft Tissue Regeneration Procedure Numbers, Europe, 2016 - 2026 15
• Figure 3 1: Dental Soft Tissue Regeneration Market by Scenario, Europe, 2016 - 2026 (€M) 18
• Figure 3 2: Dental Soft Tissue Regeneration Market by Scenario, Europe, 2016 - 2026 (US$M) 19
• Figure 4 1: Dental Soft Tissue Regeneration Market, Europe, 2019 - 2026 25
• Figure 4 2: Units Sold by Country, Dental Soft Tissue Regeneration Market, Europe, 2019 - 2026 27
• Figure 4 3: Average Selling Price by Country, Dental Soft Tissue Regeneration Market, Europe, 2019 - 2026 (€) 28
• Figure 4 4: Average Selling Price by Country, Dental Soft Tissue Regeneration Market, Europe, 2019 - 2026 (US$M) 29
• Figure 4 5: Market Value by Country, Dental Soft Tissue Regeneration Market, Europe, 2019 - 2026 (€M) 30
• Figure 4 6: Market Value by Country, Dental Soft Tissue Regeneration Market, Europe, 2019 - 2026 (US$M) 31
• Figure 4 7: Drivers and Limiters, Dental Soft Tissue Regeneration Market, Europe, 2019 35
• Figure 4 8: Leading Competitors, Dental Soft Tissue Regeneration Market, Europe, 2019 38

The EU dental soft tissue regeneration market was valued at €7.3 million in 2019. The market value is expected to increase and reach somewhere in between €8.5 and €9.9 million by 2026, depending on the impact of COVID19 on the overall market.

The vast majority of unit sales were xenograft products produced by Geistlich and Botiss, and the remainder consisted mostly of AlloDerm®, which is distributed by BioHorizons. Even if regulations surrounding the use of human tissue for soft tissue regeneration impede sales of these types of products throughout Europe, within the dental indication specifically, the regulatory hurdles are slightly less pronounced.

Some dentists in this market are using these devices to increase biotype and soft tissue thickness around implants. The number of dental regenerative matrix units sold is partly correlated with the number of dental implant procedures in a given country. This explains why, population differences aside, unit sales in Germany and Italy were slightly higher than in France, and significantly higher than in the United Kingdom.

The market for dental soft tissue regeneration consists of xenografts and allografts. Dentists mostly use soft tissue regenerative products for root coverage and ridge augmentation. Compared to other soft tissue reinforcement and regeneration markets, such as breast reconstruction and hernia repair, dental regenerative biologic matrices have not been on the European market for very long.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

RESEARCH METHODOLOGY

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

PROCEDURE NUMBERS

IMPACT OF COVID-19 ON THE EUROPE DENTAL SOFT TISSUE REGENERATION MARKET

• 3.1 INTRODUCTION
• 3.2 MULTI-SCENARIO ANALYSIS

EUROPE DENTAL SOFT TISSUE REGENERATION MARKET

• 4.1 INTRODUCTION
• 4.2 MARKET ANALYSIS AND FORECAST
• 4.3 DRIVERS AND LIMITERS
  • 4.3.1 Market Drivers
  • 4.3.2 Market Limiters
• 4.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS